PROSE Treatment

Symptoms and Treatment Success

A 2010 BostonSight report based on a survey* of more than 1,000 people with corneal disease, including 378 BostonSight® PROSE patients, found that:

  • 80% had moderate or severe eye pain
  • 72% had moderate or severe light sensitivity
  • 72% had difficulty driving at night
  • 69% had difficulty reading regular print newspapers, magazines or websites
  • 65% had difficulty with work or hobbies that require seeing up close

The survey also asked respondents about their success with a variety of treatments. Here is what they had to say about the most common:

  • 5% had significant success with oral antibiotics, fish oil or flaxseed oil
  • 6% with punctal plugs
  • 6% with topical immunosuppressant medications (cyclosporine / Restasis)
  • 10% with artificial tears, lubricant gel, or lubricant ointment
  • 10% with topical steroids

80% had significant success with BostonSight PROSE

* Survey questions refer to success with Boston Ocular Surface Prosthesis (BOS-P) and Boston Scleral Lenses used exculsively in BostonSight PROSE treatment.

BostonSight PROSE patient Ian Gonzalez
BostonSight staffer working in the manufacturing lab

Research on BostonSight PROSE Treatment

BostonSight® PROSE treatment:

“...significantly improved visual acuity and visual functioning in patients with corneal ectasia, irregular astigmatism and ocular surface disease…”
— American Journal of Ophthalmology, 2010 Jan; 149(1):54-61

  “...offers a high impact on visual acuity and on visual function with documented continued wear for 6 months in 88% of eyes. PROSE treatment is an alternative to penetrating keratoplasty for patients with corneal ectasia who are contact lens intolerant.”
— Contact Lens & Anterior Eye, 2012 Oct; 35(5):222-7

“...offers continued benefit, as defined by improved visual function and continued device wear at five years, to almost 75% of candidates with complex corneal disease.”
— Poster Presentation, Association for Research in Vision and Ophthalmology, May 2014